Inactivation of gram-positive bacteria
US-9839706-B2 · Dec 12, 2017 · US
Inactivation of gram-positive bacteria
US10953117B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10953117-B2 |
| Application number | US-201715807488-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 8, 2017 |
| Priority date | Jul 29, 2005 |
| Publication date | Mar 23, 2021 |
| Grant date | Mar 23, 2021 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A method for inactivating medically important Gram-positive bacteria including Methicillin-resistant Staphylococcus aureus (MRSA), Coagulase-Negative Staphylococcus (CONS), Streptococcus, Enterococcus and Clostridium species, comprising exposure to visible light, and in particular light within the wavelength range 400-500 nm.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for disinfecting air, contact surfaces, or materials by inactivating bacteria from one or more pathogenic Gram-positive bacterial species in the air, on the contact surfaces, or on the materials, said method comprising exposing the one or more pathogenic Gram-positive bacterial species to white light containing blue light without using a photosensitizer, wherein the one or more pathogenic Gram-positive bacterial species are selected from the group consisting of Streptococcus and Clostridium species, wherein at least a portion of the blue light that inactivates the one or more Gram-positive bacterial species consists of wavelengths in the range 400-500 nm, and wherein the method is performed outside of the human body and the contact surfaces or the materials are non-living. 2. The method according to claim 1 , wherein the portion of the blue light that inactivates the one or more Gram-positive bacterial species consists of wavelengths in the range 400-450 nm. 3. The method of claim 1 , wherein the portion of the blue light that inactivates the one or more Gram-positive bacterial species consists of wavelengths in the range 400-420 nm. 4. The method of claim 1 , wherein the portion of the blue light that inactivates the one or more Gram-positive bacterial species has a wavelength of about 405 nm. 5. A method for disinfecting air, contact surfaces, or materials by inactivating one or more pathogenic Gram-positive bacterial species in the air, on the contact surfaces, or on the materials, said method comprising exposing the one or more pathogenic Gram-positive bacterial species to white light containing blue light without using a photosensitizer, wherein the Gram-positive bacterial species are selected from the group consisting of Streptococcus and Clostridium species and further wherein at least a portion of the blue light that inactivates the one or more Gram-positive bacterial species consists of wavelengths in the range 400-420 nm, and wherein the method is performed outside of the human body and the contact surfaces of the materials are non-living.
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10953117B2 cover?
- A method for inactivating medically important Gram-positive bacteria including Methicillin-resistant Staphylococcus aureus (MRSA), Coagulase-Negative Staphylococcus (CONS), Streptococcus, Enterococcus and Clostridium species, comprising exposure to visible light, and in particular light within the wavelength range 400-500 nm.
- Who is the assignee on this patent?
- Univ Strathclyde
- What technology area does this patent fall under?
- Primary CPC classification A61L2/084. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).